SBIR/STTR Research Award
IGF::OT::IGF: WEB RESOURCE SYSTEM FOR PRESCRIPTION DRUG PROVIDERS, RESEARCHERS AND USERS: THE PRESCRIPTION DRUG ABUSE POLICY SYSTEM (PDAPS). N43DA-14-5578. PERIOD OF PERFORMANCE: JULY 1, 2014 TO DECEM
Award amount
$149,901Program and phase
SBIR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Legal Science Partners, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- NIDA
Research abstract
Prescription drug overdose has become a significant source of preventable mortality and health care utilization in the United States. Public policies are now being deployed to influence the problem at every stage from access to opioid medicines to innovative strategies for managing overdose after it occurs. Scientifically valid legal data is the starting point for the evaluation of the health impact of laws, policies and their implementation. This project will use scientifically sound, transparent methods to collect, code and publish laws, regulations and other formalized policies relevant to prescription drug abuse in a state-of-the-art interactive, web-based Prescription Drug Abuse Policy System. PUBLIC HEALTH RELEVANCE
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)